Regulatory Update Indonesia's Halal Product Assurance Agency (BPJPH) has reaffirmed that cosmetic products circulating in Indonesia must obtain halal certification by 17 October 2026. The requirement is part of Indonesia's phased implementation of the Halal Product Assurance framework and applies to cosmetics, pharmaceuticals, chemical products, genetically engineered products, and certain consumer goods. For cosmetic manufacturers, importers, and brand owners, the deadline i

Taiwan continues to reinforce its reputation as one of Asia's most advanced medical device markets, following recent regulatory developments that highlight the country's commitment to supporting innovative healthcare technologies. In May 2026, the Taiwan Food and Drug Administration (TFDA) approved a novel histotripsy technology platform, marking another example of Taiwan's growing role in facilitating access to cutting-edge medical innovations. The approval underscores the T

The regulatory landscape for medical devices in Australia continues to evolve as the Therapeutic Goods Administration advances the implementation of its Unique Device Identification (UDI) framework, a major step toward strengthening medical device traceability, patient safety, and post-market oversight. Recent updates released in 2026 highlight Australia’s continued progress toward mandatory UDI compliance, with high-risk medical devices entering key implementation phases beg

The healthcare and medical technology sector in Japan continues to evolve rapidly as the country strengthens its focus on artificial intelligence, digital healthcare innovation, and regulatory modernisation. Recent developments involving Japan’s regulatory authorities and healthcare ecosystem reflect growing efforts to support advanced healthcare technologies while maintaining strong safety, quality, and compliance standards. As one of the world’s leading healthcare technolog

The healthcare and medical technology landscape in Germany continues to evolve rapidly, driven by increasing investment in digital health, healthcare innovation, and technology-driven regulatory modernisation. As one of Europe’s leading healthcare and medical technology markets, Germany is strengthening its focus on digital transformation while supporting the integration of innovative healthcare solutions into clinical practice. For medical device manufacturers and healthcare

The regulatory landscape for medical devices in Italy continues to evolve as European authorities strengthen implementation and enforcement under the European Commission Medical Device Regulation (EU MDR). Recent developments in 2026 reflect increasing focus on compliance oversight, post-market surveillance, clinical evidence, and vigilance reporting as regulators work to ensure higher standards of safety and performance across the European medical device sector. For manufact

The regulatory landscape in Thailand continues to evolve as the Thai Food and Drug Administration advances its digital transformation efforts to modernise medical device regulation and improve regulatory efficiency. Recent developments introduced in 2026 highlight Thailand’s commitment to strengthening regulatory systems through digitalisation, streamlined submissions, and improved oversight of healthcare products. For medical device manufacturers, these changes signal an imp

The regulatory landscape in the United Arab Emirates is undergoing significant transformation, with the country continuing to strengthen and centralise oversight of healthcare products through the **Emirates Drug Establishment> (EDE). Recent developments in 2026 highlight the UAE’s broader strategy to modernise healthcare regulation, improve efficiency, and position the country as a leading regional hub for healthcare innovation and market access. For medical device and pharm

International regulatory collaboration continues to play an increasingly important role in accelerating access to innovative healthcare technologies. In May 2026, the Health Sciences Authority of Singapore and China’s National Medical Products Administration signed a renewed Memorandum of Understanding (MOU), expanding their long-standing partnership in health product regulation. The updated agreement signals a stronger commitment to regulatory cooperation, innovation, and th

Saudi Arabia continues to enhance its regulatory framework for medical devices, with recent updates reinforcing the importance of accurate product classification and compliance. In early 2026, the Saudi Food and Drug Authority introduced updated product classification guidance, providing clearer requirements for how products are categorised and regulated within the Kingdom. This development reflects Saudi Arabia’s broader ambition to establish a more structured, transparent,

Regional regulatory collaboration in Southeast Asia is entering a new phase, as Medical Device Authority Malaysia and the Thai Food and Drug Administration officially announce the full implementation of their Medical Device Regulatory Reliance Programme in May 2026. This milestone follows the successful completion of a three-month pilot phase and represents a significant step toward regulatory harmonisation and more efficient market access across the ASEAN region. From Pilot

India continues to advance its regulatory framework for medical devices, with recent developments signalling a stronger and more structured approach to oversight, compliance, and market control. Under the leadership of the Central Drugs Standard Control Organisation, the country is expanding the scope of regulated medical devices while reinforcing licensing and compliance requirements across the sector. These changes are part of India’s broader effort to align with internatio